
    
      Membranous nephropathy with heavy proteinuria have high risks of progressing to CRF.

      Tripterygium (TW) is a Chinese traditional patent drugs, it can reduce proteinuria of chronic
      glomerular nephritis,such as IgA nephropathy. So, we designed this randomized, prospective
      clinical trial to assess the efficacy and safety of TW versus Valsartan in the treatment of
      heavy proteinuria of MN.
    
  